Also trades as: INDV.L (LSE) · $vol 5M
INDV NASDAQ
Indivior Pharmaceuticals Inc
1W: +2.0%
1M: -3.5%
3M: -15.7%
YTD: -3.3%
1Y: +36.7%
3Y: +79.1%
5Y: +117.4%
$34.72
+0.16 (+0.46%)
After Hours: $36.80 (+2.08, +5.98%)
Weekly Expected Move ±4.8%
$31
$33
$34
$36
$38
Credit Risk of going bust: lower than 74% of companies Debt: 10.6% of company value Bonds: $90.4M held by 58 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.31 (down 99.1%), Indivior Pharmaceuticals Inc would be worth roughly what it owes.
Total debt $509.0M against a stock market value of $4.31B.
Distance to default 8.36 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $252.5M (short-term plus half of long-term), stock volatility 36.3%; Altman Z 3.48. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.31 (down 99.1%), Indivior Pharmaceuticals Inc would be worth roughly what it owes.
Total debt $509.0M against a stock market value of $4.31B.
Distance to default 8.36 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $252.5M (short-term plus half of long-term), stock volatility 36.3%; Altman Z 3.48. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2025-03-04
Earliest Filing
2025-03-04
Latest Filing
investor: 4
Counterparties (Filed by INDV)
4 relationshipsCompanies named in INDV's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Oaktree Value Opportunities Fund, L.P. | — | investor | Counterparty to amended and restated relationship agreement regarding board appointments and governance. | 2025-03-04 | View |
| Oaktree London Liquid Value Opportunities Fund (VOF), L.P. | — | investor | Counterparty to amended and restated relationship agreement regarding board appointments and governance. | 2025-03-04 | View |
| Oaktree Phoenix Investment Fund, L.P. | — | investor | Counterparty to amended and restated relationship agreement regarding board appointments and governance. | 2025-03-04 | View |
| Boston Patriot Arlington ST LLC | — | investor | Counterparty to amended and restated relationship agreement regarding board appointments and governance. | 2025-03-04 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-15 | Shareholder Vote | View | |
| 2026-10-06 | Other Events | View | |
| 2026-09-17 | Regulation FD; Other Events; Exhibits | View | |
| 2026-09-15 | Termination of Agreement; Exhibits | View | |
| 2026-08-03 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-08-03 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-08-03 | Regulation FD; Exhibits | View | |
| 2026-05-15 | Officer/Director Change; Shareholder Vote | View | |
| 2026-05-04 | Regulation FD; Other Events; Exhibits | View | |
| 2026-04-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-17 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2026-03-13 | Other Events; Financial Statements and Exhibits | View | |
| 2026-03-12 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-26 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2026-01-08 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-22 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-18 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-12-15 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holde | View | |
| 2025-11-20 | Termination of Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exh | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR